As mentioned in our newsletter, Dividend Aristocrat Walgreen Boots (WBA) is one of the laggards in 2019 and down almost 13% year-to-date. Last week, WBA already managed expectations by lowering growth earnings in fiscal 2020 because of the low reimbursement rates for prescription drugs, and competition from online retailers such as Amazon.com (AMZN).
According to Reuters: “Walgreens Boots Alliance Inc has been exploring whether to go private following private equity interest in the U.S drug store chain, which has a market value of more than $55 billion, according to people familiar with the matter. ”
The stock rose by 9% in the last 5 days.
Below the year-to-date performance chart of the 3 worst performing dividend aristocrats.